[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.168.21. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 1976

Advances in Cancer of the Breast

Arch Surg. 1976;111(8):843. doi:10.1001/archsurg.1976.01360260011001

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

In this issue of the Archives (p 877), Dr Puga and his colleagues have made a clear presentation of data on therapeutic oophorectomy performed for disseminated carcinoma of the breast in the years 1960 to 1964. The results are of interest because they oppose the conventional thinking that the disease-free interval, age of the patient, and tumor histology have important implications in the likelihood of response.

During the years since these patients were treated, several innovations in management have emerged for the patient with advanced cancer of the breast. These advances have followed two basic strategies: nonhormonal chemotherapy, and additive or ablative endocrine manipulation based on tumor receptors. Both are demonstrating success.

Progress in nonhormonal chemotherapy in patients with cancer of the breast is one of the most exciting of all recent medical advances. After numerous trials with individual agents, most medical oncologists are now using multiple drug approaches. The

First Page Preview View Large
First page PDF preview
First page PDF preview
×